IONS earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E -27.14. Updated 2026-07-23.
Ionis Pharmaceuticals (IONS) Research Hub
Ionis Pharmaceuticals (IONS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 54.21 USD (-3.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -27.14, market cap 8.64B. This hub links to the full technical, earnings and options research available for IONS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 54.21 USD (-3.23%) |
| 52-week range | 50.01 USD – 86.67 USD |
| Trend regime | Range |
| 14-day RSI | 44.3 (Bearish) |
| Trailing P/E | -27.14 |
| Market cap | 8.64B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for IONS
Covered Call on IONS: how it works, illustrative setup around the real 54.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IONS: how it works, illustrative setup around the real 54.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IONS: how it works, illustrative setup around the real 54.21 USD price, max profit/loss, breakeven and when to use it. Educational.
IONS technical analysis: range, last 54.21 USD, RSI 44.3, 52w range 50.01 USD–86.67 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IONS in?
Ionis Pharmaceuticals (IONS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IONS in an uptrend or downtrend?
As of 2026-09-11, IONS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IONS's trailing P/E ratio?
IONS's trailing P/E is -27.14, with a market cap of 8.64B. See the earnings research page for full valuation detail.
When does IONS next report earnings?
IONS is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of -1.09141 USD.